MYOVIEW set marquage 0.23 mg fl 5 pce
7680536530221
CH-53653
V09GA02
17.01.7.
Reimbursement limitations:
MAX2INJIN48H
Au maximum 2 injections dans les 48 heures.
1 / 2
google
Details
- Product number
- 5365301
- CPT
- -
- Packaging group
- 5
- Unit
- Flasche(n)
- Composition
- Praeparatio cryodesiccata: tetrofosminum 0.23 mg, stannosi chloridum dihydricum, dinatrii sulfosalicylas, natrii gluconas, natrii hydrogenocarbonas, pro vitro corresp. natrium 0.65 mg.
Articles (1)
Myoview, Markierungsbesteck
Markierungsbesteck
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
0.23 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
0.65 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1668.05
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2000
Authorization holder
GE Healthcare AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 53653
- Drug name
- Myoview, Markierungsbesteck
- Galenic form
- KIT
- ATC Code
- V09GA02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 03/06/1999
- Authorization expiration date
- 31/12/9999
- IT number
- 17.01.7.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MYOVIEW set marquage 0.23 mg fl 5 pce
- Description (DE)
- MYOVIEW Markierungsbesteck 0.23 mg Fl 5 Stk
- Market launch
- 03/06/1999
- Narcotic (BTM)
- No